[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343008-105":59,"doc-detail-343008-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","inhibition-of-cancer-stem-like-cells-by-curcumin-and-other-polyphenol-derivatives-in-mda-mb-231-tnbc-cells","Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells","","Triple-negative breast cancer (TNBC) represents a highly aggressive subtype that often relapses after initial chemotherapy response due to the presence of breast cancer stem cells (BCSCs). BCSCs sustain tumor growth through self-renewal and pluripotency and resist conventional therapies, leaving few specific targets. This study evaluates six synthetic compounds derived from EGCG and curcumin, testing their cellular and molecular effects in a TNBC mesenchymal stem-like cell line. BCSC activity was assessed via mammosphere inhibition and Western blot analysis of markers, and drug combinations were examined for synergy with doxorubicin, cisplatin, and paclitaxel. Results indicate compound-specific cytotoxicity, with TL3 plus doxorubicin and cisplatin showing synergistic effects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-cancer-stem-like-cells-by-curcumin-and-other-polyphenol-derivatives-in-mda-mb-231-tnbc-cells/343008/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-cancer-stem-like-cells-by-curcumin-and-other-polyphenol-derivatives-in-mda-mb-231-tnbc-cells/343008.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are breast cancer stem cells important in triple-negative breast cancer (TNBC)?","Question",{"text":113,"@type":114},"BCSCs help drive TNBC aggressiveness by supporting self-renewal/pluripotency and contributing to invasion and metastasis. They also resist conventional therapies, contributing to relapse and poor long-term survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What compounds were evaluated in the study?",{"text":118,"@type":114},"The study tested six synthetic compounds derived from EGCG (TL1, TL2) and curcumin derivatives (TL3, TL4, TL5, TL6) in a TNBC mesenchymal stem-like cell line.",{"name":120,"@type":111,"acceptedAnswer":121},"How did the researchers assess effects on BCSCs and combination therapy?",{"text":122,"@type":114},"BCSC activity was evaluated using a mammosphere inhibition assay and by studying BCSC markers with Western blotting. A drug combination assay was then used to assess potential synergy with doxorubicin, cisplatin, and paclitaxel.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343008,1790813096,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nInhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells  \nMaria Ros 1,†, Gerard Riesco-Llach 2,†, Emma Polonio-Alcalá 1, Pere Miquel Morla-Barcelo 3, Santiago Ruiz-Martínez 4, Lidia Feliu 2, *, Marta Planas 2 and Teresa Puig 1, *  \nCitation: Ros, M.; Riesco-Llach, G.; Polonio-Alcalá, E.; Morla-Barcelo, P.M.; Ruiz-Martínez, S.; Feliu, L.; Planas, M.; Puig, T. Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. Int. J. Mol. Sci. 2024, 25, 7446. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25137446](10.3390/ijms25137446)  \nAcademic Editors: Francisco Les, Marta Sofía Valero, María  \nPilar Arruebo and Nam Deuk Kim  \nReceived: 10 May 2024  \nRevised: 1 July 2024  \nAccepted: 4 July 2024  \nPublished: 6 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, 17003 Girona, Spain  \n2 Laboratori d’Innovació en Processos i Productes de Síntesi Orgànica (LIPPSO), Department of Chemistry, University of Girona, 17003 Girona, Spain; [marta.planas@udg.edu](marta.planas@udg.edu) (M.P.)  \n3 Grupo Multidisciplinar de Oncología Traslacional, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, 07122 Palma, Spain  \n4 Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, Sahlgrenska Center for Cancer Research, University of Gothenburg, 405 30 Gothenburg, Sweden  \n* Correspondence: [lidia.feliu@udg.edu](lidia.feliu@udg.edu) (L.F.); [teresa.puig@udg.edu](teresa.puig@udg.edu) (T.P.)† These authors contributed equally to this work.  \nAbstract: Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers and is highly aggressive. Despite an initial positive response to chemotherapy, most patients experience rapid disease progression leading to relapse and metastasis. This is attributed to the presence of breast cancer stem cells (BCSCs) within the tumor, which are characterized by self-renewal, pluripotency, and resistance mechanisms. Targeting BCSCs has become critical as conventional therapies fail to eradicate them due to a lack of specific targets. Curcumin, a polyphenol derived from turmeric (Curcuma longa), exhibits anticancer effects against breast cancer cells and BCSCs. The use of curcumin derivatives has been suggested as an approach to overcome the bioavailability and solubility problems of curcumin in humans, thereby increasing its anticancer effects. The aim of this study was to evaluate the cellular and molecular effects of six synthetic compounds derived from the natural polyphenol epigallocatechin gallate (EGCG) (TL1, TL2) and curcumin derivatives (TL3, TL4, TL5, and TL6) on a TNBC mesenchymal stem-like cell line. The activity of the compounds against BCSCs was also determined by a mammosphere inhibition assay and studying different BCSC markers by Western blotting. Finally, a drug combination assay was performed with the most promising compounds to evaluate their potential synergistic effects with the chemotherapeutic agents doxorubicin, cisplatin, and paclitaxel. The results showed that compounds exhibited specific cytotoxicity against the TNBC cell line and BCSCs. Interestingly, the combination of the curcumin derivative TL3 with doxorubicinand cisplatin displayed a synergistic effect in TNBC cells.  \nKeywords: polyphenols; curcumin; triple-negative breast cancer; cancer stem cells  \n1. Introduction  \nBreast cancer (BCa) is the most common and second most f","cbCailLCtTcIprY7","https://ap.wps.com/l/cbCailLCtTcIprY7","pdf",2556249,21,"English","# Introduction\n## Background on TNBC and chemotherapy resistance\n## Role of BCSCs in tumor aggressiveness\n## Rationale for targeting BCSCs and testing polyphenol derivatives","[{\"question\":\"Why are breast cancer stem cells important in triple-negative breast cancer (TNBC)?\",\"answer\":\"BCSCs help drive TNBC aggressiveness by supporting self-renewal/pluripotency and contributing to invasion and metastasis. They also resist conventional therapies, contributing to relapse and poor long-term survival.\"},{\"question\":\"What compounds were evaluated in the study?\",\"answer\":\"The study tested six synthetic compounds derived from EGCG (TL1, TL2) and curcumin derivatives (TL3, TL4, TL5, TL6) in a TNBC mesenchymal stem-like cell line.\"},{\"question\":\"How did the researchers assess effects on BCSCs and combination therapy?\",\"answer\":\"BCSC activity was evaluated using a mammosphere inhibition assay and by studying BCSC markers with Western blotting. A drug combination assay was then used to assess potential synergy with doxorubicin, cisplatin, and paclitaxel.\"}]","Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells | PDF",1790049373,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2090da39857c01bae9598f4e6fe5d831.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4e8962cd9f4f77520bf8e9870037888.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5fd958e24c2a66a56c6a7fd0f9dc1a4.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/680975a90d7b97502d843b9ff5b204ba.webp",980,1385]